CLINICAL_TRIALS
trial_result
· 2020-01-13
Clinical Trial Update: Plegridy Satisfaction Study in Participants [Phase 4]
Summary
Phase 4 trial update for Plegridy in participants with relapsing-remitting multiple sclerosis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biogen | Conditions: Relapsing-Remitting Multiple Sclerosis (RRMS) | Phase 4 | Status: COMPLETED | Results posted: 2020-01-13